Related Experiment Video
Updated: Oct 20, 2025
10:31
Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma
Published on: August 9, 2016
12.9K
Six intragastric balloons: Which to choose?
George Stavrou1, Anne Shrewsbury2, Katerina Kotzampassi2
1Department of Colorectal Surgery, Addenbrooke's Hospital, Cambridge CB22QQ, United Kingdom. stavgd@gmail.com.
World Journal of Gastrointestinal Endoscopy
|September 13, 2021
Summary
Intragastric balloons (IGBs) offer a less invasive, non-surgical option for obesity treatment by promoting satiety. However, their long-term effectiveness is debated, with weight regain being common after removal.
Area of Science:
- Bariatric Endoscopy
- Obesity Management
- Gastroenterology
Background:
- Endoscopically placed intragastric balloons (IGBs) are a recognized, reversible, non-surgical method for obesity treatment.
- IGBs facilitate weight loss by inducing satiety and reducing food intake, bridging the gap between lifestyle changes and bariatric surgery.
Purpose of the Study:
- To review the advantages and disadvantages of various intragastric balloon types.
- To guide physicians and patients in selecting the most effective and safest IGB for weight loss.
Main Methods:
- Analysis of six common intragastric balloons: Orbera, Spatz3, ReShape Duo, Elipse (liquid-filled), Heliosphere, and Obalon (gas-filled).
- Inclusion of details on adjustable (Spatz3) and swallowable (Obalon, Elipse) balloon systems.
Main Results:
- IGBs provide a continuous sensation of satiety, aiding adherence to low-calorie diets.
- Evidence suggests limited sustainable effectiveness for many patients, with a tendency for weight regain post-removal.
Conclusions:
- A comprehensive understanding of IGB pros and cons is crucial for optimizing treatment selection.
- Careful consideration of different balloon types is necessary to maximize efficacy and patient safety in obesity management.
